Trial medication for inflammatory bowel diseases

Are you:

• a healthy male or female
• aged from 18 en 55 years (inclusive)
• with a BMI 18,5 to 27,0 kg/m² 
• a non-smoker or stopped smoking min. 6 months before the first dose of study medication) 
• not using daily medication

What does this trial involve?

SGS trial BE-80-2100577 part 1 investigates the treatment of inflammatory bowel diseases. You will have the following appointments over 12 weeks:

• screening
• 5-day (4-night) stay
• 10 short follow-up visits
• a final examination

Take part in this trial and

• help us develop tomorrow's medicines
• and receive a generous tax-free (in Belgium) payment of € 2550

View information leaflet